Taiwan ACE Beads for Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia
Safety and Efficacy of Prostatic Artery Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia
Sponsor: National Cheng Kung University
This NA trial investigates Benign Prostatic Hyperplasia (BPH) and Lower Urinary Tract Symptom and is currently ongoing. National Cheng Kung University leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Dec 2025 — Present [monthly]
Unknown NA
-
Sep 2025 — Dec 2025 [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 5 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Nov 2019 — Jan 2021 [monthly]
Recruiting NA
-
Sep 2019 — Nov 2019 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2019 [monthly]
Recruiting NA
-
Aug 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cheng Kung University
- National Cheng-Kung University Hospital
- National Research Program for Biopharmaceuticals, Taiwan
- The Industrial Technology Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .